Pictet Asset Management (UK)’s Array Biopharma Inc ARRY Stock Holding History

Pictet Asset Management (UK)’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-428,974	Closed	-$19.9M	–	1059
2019 Q2	$19.9M	Sell	428,974 -1,634,985	-79%	-$45.9M	0.04%	385
2019 Q1	$50.3M	Sell	2,063,959 -1,473,412	-42%	-$30.7M	0.11%	239
2018 Q4	$50.4K	Buy	3,537,371 +1,063,352	+43%	+$16.1M	0.13%	210
2018 Q3	$37.6M	Buy	2,474,019 +677,180	+38%	+$10.4M	0.08%	292
2018 Q2	$30.2M	Buy	1,796,839 +315,708	+21%	+$5.02M	0.07%	311
2018 Q1	$24.2M	Buy	1,481,131 +1,225,631	+480%	+$19.6M	0.06%	347
2017 Q4	$3.27M	Sell	255,500 -27,200	-10%	-$309K	0.01%	739
2017 Q3	$3.48M	Buy	+282,700	New	+$2.63M	0.01%	703

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Pictet Asset Management (UK)'s ARRY Position: Q3 2019 in Review

Pictet Asset Management (UK) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 428,974 shares — an estimated $19.9M sold.

Pictet Asset Management (UK) first reported a position in ARRY in Q3 2017 and held it in 8 quarters. The position peaked at $50.3M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Pictet Asset Management (UK) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 428,974 Array Biopharma Inc shares in Q3 2019, an estimated $19.9M.
Pictet Asset Management (UK) first reported a position in Array Biopharma Inc in Q3 2017 and held it in 8 quarters.
Pictet Asset Management (UK)'s Array Biopharma Inc position peaked at $50.3M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2019, filed 14 Nov 2019.